Pronađeno: 1-5 / 5 radova

Autori: Ozelo M

>> Filter: Samo Article i Review

>> Sve godine

Naslov Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2 (Meeting Abstract)
Autori Tiede Andreas Janic Dragana M  Ozelo M Santagostino E Korsholm Lars Matytsina Irina Lentz SR 
Info HAEMOPHILIA, (2018), vol. 24 br. , Suppl. S1, str. 52-52
Projekat Alnylam; Baxter/Baxalta/Shire; Bayer; Biogen Idec; Biotest; CSL Behring; Novo Nordisk A/S; Octapharma; Pfizer; Roche; Sobi; Baxter; Shire
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Interim results from a large multinational extension trial (guardian (TM) 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A (Letter)
Autori Lentz SR Cerqueira MH Janic Dragana M  Kempton CL Matytsina Irina Misgav M Oldenburg J Ozelo M Recht M Rosholm A Savic Aleksandar D  Suzuki Takashi Tiede Andreas Santagostino E 
Info HAEMOPHILIA, (2016), vol. 22 br. 5, str. E445-E449
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Changes in Annualized Bleeding Rate Over Time and Relationship with Dosing of Tutoctocog a During the Guardian Program (Meeting Abstract)
Autori Mancuso ME Ozelo M Janic Dragana M  Matytsina Irina Landorph Andrea Zeuthan Niels Roveda A Pellegrino G 
Info HAEMATOLOGICA, (2015), vol. 100 br. , Suppl. 3, str. 65-66
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Results from a large multinational clinical trial (guardian (TM) 3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics (Article)
Autori Kulkarni R Karim Abdul F Glamocanin S Janic Dragana M  Vdovin V Ozelo M Rageliene L Carboni E Laguna P Dobaczewski G Seremetis S Lindblom A Santagostino E 
Info HAEMOPHILIA, (2013), vol. 19 br. 5, str. 698-705
Projekat Novo Nordisk A/S (Bagsvaerd, Denmark)
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Safety and efficacy of turoctocog alfa in the prevention and treatment of bleeding episodes in paediatric patients with severe haemophilia A and below 12 years of age (Meeting Abstract)
Autori Kulkarni R Karim Abdul F Glamocanin S Janic Dragana M  Vdovin V Ozelo M Rageliene L Carboni E Laguna P Dobaczewski G Santagostino E 
Info HAEMOPHILIA, (2012), vol. 18 br. 5, str. 829-829
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX